Furazolidone‐containing triple and quadruple eradication therapy for initial treatment for <i>Helicobacter pylori</i> infection: A multicenter randomized controlled trial in China

Abstract

Furazolidone-containing therapies, particularly the tested 10-day quadruple therapy, exhibited satisfactory efficacy and safety. This 10-day quadruple therapy represents a promising initial treatment strategy for Chinese patients.